Hong Kong Pharma Digital Technology Holdings Limited
HKPD · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | |
|---|---|---|---|
| Market Cap | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 |
| % Growth | 21.7% | 32.9% | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | 11.9% | 21.3% | 21.8% |
| EBITDA | $0 | $0 | $0 |
| % Margin | 5.9% | 15.2% | 14% |
| Net Income | -$0 | $0 | $0 |
| % Margin | -0.1% | 8% | 7.9% |
| EPS Diluted | -0.003 | 0.18 | 0.091 |
| % Growth | -101.7% | 98.5% | – |
| Operating Cash Flow | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 |